These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 18571548)

  • 21. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
    Li W; Zhang L; Wang Z; He X; Lin H; Wang Y; Yuan J; Xie X; Zhang X; Qin Y; Huang P
    Int J Clin Pract; 2022; 2022():2726686. PubMed ID: 35989868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
    Li G; Wang T; Gou Y; Zeng R; Liu D; Duan Y; Liu B
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107037. PubMed ID: 33242833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Predictive value of peripheral blood lymphocyte subsets for children with intravenous immunoglobulin-resistant Kawasaki disease].
    Xue Y; Yin J; Xu L; Dang LH; Wang C; Cui YQ; Zhang XJ; Li CW
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Dec; 25(12):1211-1218. PubMed ID: 38112137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
    Li SY; Ding Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):244-249. PubMed ID: 36946157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease.
    Huang CN; Wu FF; Chang YM; Huang HC; Lin MT; Wang JK; Wu MH
    J Formos Med Assoc; 2021 Oct; 120(10):1884-1889. PubMed ID: 33358267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Verification of Current Risk Scores for Kawasaki Disease in Korean Children.
    Shin J; Lee H; Eun L
    J Korean Med Sci; 2017 Dec; 32(12):1991-1996. PubMed ID: 29115081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease.
    Piram M; Darce Bello M; Tellier S; Di Filippo S; Boralevi F; Madhi F; Meinzer U; Cimaz R; Piedvache C; Koné-Paut I
    Sci Rep; 2020 Feb; 10(1):3125. PubMed ID: 32080307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin resistance in Kawasaki disease patients: prediction using clinical data.
    Lam JY; Song MS; Kim GB; Shimizu C; Bainto E; Tremoulet AH; Nemati S; Burns JC
    Pediatr Res; 2024 Feb; 95(3):692-697. PubMed ID: 36797460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.
    Wang Y; Li Z; Hu G; Hao S; Deng X; Huang M; Ren M; Jiang X; Kanegaye JT; Ha KS; Lee J; Li X; Jiang X; Yu Y; Tremoulet AH; Burns JC; Whitin JC; Shin AY; Sylvester KG; McElhinney DB; Cohen HJ; Ling XB;
    PLoS One; 2016; 11(12):e0167434. PubMed ID: 28002448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A retrospective analysis of 602 Kawasaki disease cases with electronic data capture system].
    Xie L; Zhou C; Wang R; Xiao T; Shen J; Huang M
    Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):34-9. PubMed ID: 25748402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of autophagy markers in IVIG-resistant Kawasaki disease and the establishment of prediction model.
    Zhou Y; Wu Y; Yuan C; Yin W; Wang B; Ding Y
    BMC Pediatr; 2023 Dec; 23(1):642. PubMed ID: 38114939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verification of "Japanese Scoring Systems" to Predict IVIG Resistance and Identification of Predictors for IVIG Resistance in Thai Children with Kawasaki Disease.
    Jarutach J; Roymanee S; Wongwaitaweewong K
    Pediatr Cardiol; 2021 Dec; 42(8):1799-1804. PubMed ID: 34173835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary artery status of patients with transient fever 24-36 h after first IVIG infusion did not differ from that seen in responsive patients.
    Baek JS; Yu JJ; Kim MJ; You J; Jun HO; Kim YH; Ko JK
    Pediatr Rheumatol Online J; 2018 Dec; 16(1):83. PubMed ID: 30594188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?
    Fabi M; Corinaldesi E; Pierantoni L; Mazzoni E; Landini C; Bigucci B; Ancora G; Malaigia L; Bodnar T; Di Fazzio G; Lami F; Valletta E; Cicero C; Biasucci G; Iughetti L; Marchetti F; Sogno Valin P; Amarri S; Brusa S; Sprocati M; Maggiore G; Dormi A; Lanzoni P; Donti A; Lanari M
    PLoS One; 2018; 13(9):e0202658. PubMed ID: 30180185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
    Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease.
    Chang LS; Lin YJ; Yan JH; Guo MM; Lo MH; Kuo HC
    BMC Pediatr; 2020 Aug; 20(1):398. PubMed ID: 32838756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease.
    Bar-Meir M; Kalisky I; Schwartz A; Somekh E; Tasher D;
    J Pediatric Infect Dis Soc; 2018 Feb; 7(1):25-29. PubMed ID: 28062554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.